ELNORE CUSHNIE: Open Payments
NPI 1306596309 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,873 in 130 payments from 10 companies in 2025. Trend: 2023 $1,592 · 2024 $2,224 · 2025 $2,873
Food & beverage: $2,762Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $772 |
| Teva Pharmaceuticals USA, Inc. | 31 | $730 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $693 |
| Otsuka America Pharmaceutical, Inc. | 13 | $220 |
| Alkermes, Inc. | 5 | $203 |
| Neurocrine BioSciences, Inc. | 3 | $144 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, INGREZZA, REXULTI, LYBALVI, UZEDY, ARISTADA.
Industry payments across NY — which companies pay providers there.
